Home Medical Devices Continuous Blood Glucose Monitoring Market Size, Share & Forecast by 2030

Continuous Blood Glucose Monitoring Market Size, Share & Trends Analysis Report By Product (Transmitter, Receiver, Sensor, Insulin Pump), By End-User (Hospitals and Clinics, Homecare, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2022-2030

Report Code: SRMD866DR
Last Updated : Aug 12, 2024
Author : Straits Research
Starting From
USD 2300
Buy Now

Table Of Content

  1. Executive Summary

    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends

    1. Global Continuous Blood Glucose Monitoring Market Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Transmitter
        1. By Value
      3. Receiver
        1. By Value
      4. Sensor
        1. By Value
      5. Insulin Pump
        1. By Value
    3. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals and Clinics
        1. By Value
      3. Homecare
        1. By Value
      4. Others
        1. By Value
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Transmitter
        1. By Value
      3. Receiver
        1. By Value
      4. Sensor
        1. By Value
      5. Insulin Pump
        1. By Value
    3. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals and Clinics
        1. By Value
      3. Homecare
        1. By Value
      4. Others
        1. By Value
    4. U.S.
      1. By Product
        1. Introduction
          1. Product By Value
        2. Transmitter
          1. By Value
        3. Receiver
          1. By Value
        4. Sensor
          1. By Value
        5. Insulin Pump
          1. By Value
      2. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals and Clinics
          1. By Value
        3. Homecare
          1. By Value
        4. Others
          1. By Value
    5. Canada
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Transmitter
        1. By Value
      3. Receiver
        1. By Value
      4. Sensor
        1. By Value
      5. Insulin Pump
        1. By Value
    3. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals and Clinics
        1. By Value
      3. Homecare
        1. By Value
      4. Others
        1. By Value
    4. U.K.
      1. By Product
        1. Introduction
          1. Product By Value
        2. Transmitter
          1. By Value
        3. Receiver
          1. By Value
        4. Sensor
          1. By Value
        5. Insulin Pump
          1. By Value
      2. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals and Clinics
          1. By Value
        3. Homecare
          1. By Value
        4. Others
          1. By Value
    5. Germany
    6. France
    7. Spain
    8. Italy
    9. Russia
    10. Nordic
    11. Benelux
    12. Rest of Europe
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Transmitter
        1. By Value
      3. Receiver
        1. By Value
      4. Sensor
        1. By Value
      5. Insulin Pump
        1. By Value
    3. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals and Clinics
        1. By Value
      3. Homecare
        1. By Value
      4. Others
        1. By Value
    4. China
      1. By Product
        1. Introduction
          1. Product By Value
        2. Transmitter
          1. By Value
        3. Receiver
          1. By Value
        4. Sensor
          1. By Value
        5. Insulin Pump
          1. By Value
      2. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals and Clinics
          1. By Value
        3. Homecare
          1. By Value
        4. Others
          1. By Value
    5. Korea
    6. Japan
    7. India
    8. Australia
    9. Taiwan
    10. South East Asia
    11. Rest of Asia-Pacific
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Transmitter
        1. By Value
      3. Receiver
        1. By Value
      4. Sensor
        1. By Value
      5. Insulin Pump
        1. By Value
    3. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals and Clinics
        1. By Value
      3. Homecare
        1. By Value
      4. Others
        1. By Value
    4. UAE
      1. By Product
        1. Introduction
          1. Product By Value
        2. Transmitter
          1. By Value
        3. Receiver
          1. By Value
        4. Sensor
          1. By Value
        5. Insulin Pump
          1. By Value
      2. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals and Clinics
          1. By Value
        3. Homecare
          1. By Value
        4. Others
          1. By Value
    5. Turkey
    6. Saudi Arabia
    7. South Africa
    8. Egypt
    9. Nigeria
    10. Rest of MEA
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Transmitter
        1. By Value
      3. Receiver
        1. By Value
      4. Sensor
        1. By Value
      5. Insulin Pump
        1. By Value
    3. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals and Clinics
        1. By Value
      3. Homecare
        1. By Value
      4. Others
        1. By Value
    4. Brazil
      1. By Product
        1. Introduction
          1. Product By Value
        2. Transmitter
          1. By Value
        3. Receiver
          1. By Value
        4. Sensor
          1. By Value
        5. Insulin Pump
          1. By Value
      2. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals and Clinics
          1. By Value
        3. Homecare
          1. By Value
        4. Others
          1. By Value
    5. Mexico
    6. Argentina
    7. Chile
    8. Colombia
    9. Rest of LATAM
    1. Continuous Blood Glucose Monitoring Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Abbott
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Dexom Inc.
    3. Roche Diagnostics
    4. Bayer AG
    5. Medtronic Plc.
    6. Novo Nordisk
    7. Ypsomed AG
    8. Senseonics Incorporated
    9. Insulet Corporation.
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
Continuous Glucose Monitoring Systems Market Size The global continuous glucose monitoring systems market size was valued at USD 2.94 billion in 2022 and is projected to reach USD 16.59 billion by 2031, growing at a CAGR of 21.2%
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report


We are featured on :